Social networks
45 355 1,800Activities
Technologies
Entity types
Location
1460 Broadway, New York, NY 10036, USA
New York
United States of America
Employees
Scale: 11-50
Estimated: 8
Engaged catalyst
2Added in Motherbase
3 years, 6 months agoNeurobit is building a Universal health analytics platform using sleep as a biomarker across age, gender and race.
Every year over 26 million suffer heart failure, 15 million suffer a stroke and 10 million develop dementia. Most of these incidents can be predicted years before they happen. Neurobit uses physiological signals collected during sleep to uncover these patterns. Using sleep as a biomarker, Neurobit is building a Universal health analytics platform with their state-of-the-art AI models, trained on over a trillion data points of multi-channel physiological data to operate across devices, signals and disease conditions.
Neurobit's technologies are trusted by 120+ universities, hospitals and R&D centers from across the world.
Contact us to find out how our technologies can help you improve care and deliver better outcomes.
Neuroscience, Sleep Science, Neuromodulation, Neurotechnology, Sleep Score, Insomnia, sleep apnea, Smart mattress, Sleep health, Sleep Fitness, digitalhealth, Remote patient monitoring, Predictive Health, Population Health, Health Engine, Ageing, Stroke, and Pedriatrics
Neurobit uses AI to simplify the analysis of health data for better clinical decisions. Our technology provides fast and accurate analysis, starting with sleep data (Polysomnography). Visit our webpage to learn how we're revolutionizing healthcare.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Entrepreneur First Startup accelerator & VC, Venture Capital and Private Equity Principals | Entrepreneur First Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 19 Mar 2023 | | |
![]() Startupbootcamp Venture Capital and Private Equity Principals | Startupbootcamp Venture Capital and Private Equity Principals | Not capitalistic Not partnership Event 1 Nov 2018 | |